Wisp1 is a circulating factor that stimulates proliferation of adult mouse and human beta cells.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
25 11 2020
Historique:
received: 13 02 2019
accepted: 16 10 2020
entrez: 26 11 2020
pubmed: 27 11 2020
medline: 15 12 2020
Statut: epublish

Résumé

Expanding the mass of pancreatic insulin-producing beta cells through re-activation of beta cell replication has been proposed as a therapy to prevent or delay the appearance of diabetes. Pancreatic beta cells exhibit an age-dependent decrease in their proliferative activity, partly related to changes in the systemic environment. Here we report the identification of CCN4/Wisp1 as a circulating factor more abundant in pre-weaning than in adult mice. We show that Wisp1 promotes endogenous and transplanted adult beta cell proliferation in vivo. We validate these findings using isolated mouse and human islets and find that the beta cell trophic effect of Wisp1 is dependent on Akt signaling. In summary, our study reveals the role of Wisp1 as an inducer of beta cell replication, supporting the idea that the use of young blood factors may be a useful strategy to expand adult beta cell mass.

Identifiants

pubmed: 33239617
doi: 10.1038/s41467-020-19657-1
pii: 10.1038/s41467-020-19657-1
pmc: PMC7689468
doi:

Substances chimiques

CCN Intercellular Signaling Proteins 0
CCN4 protein, human 0
CCN4 protein, mouse 0
Culture Media 0
Proto-Oncogene Proteins 0
Recombinant Proteins 0
Proto-Oncogene Proteins c-akt EC 2.7.11.1

Types de publication

Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5982

Références

J Cell Commun Signal. 2018 Sep;12(3):539-548
pubmed: 29129025
Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13245-50
pubmed: 15340143
Int J Clin Exp Pathol. 2015 Nov 01;8(11):15489-96
pubmed: 26823919
Am J Pathol. 2004 Sep;165(3):855-67
pubmed: 15331410
Eur J Pharmacol. 2016 Oct 5;788:90-97
pubmed: 27321870
J Biol Chem. 2015 May 29;290(22):14004-18
pubmed: 25864198
J Cell Commun Signal. 2009 Dec;3(3-4):163-5
pubmed: 19779848
Diabetes. 1988 Dec;37(12):1678-83
pubmed: 3056761
Expert Opin Ther Targets. 2012 Dec;16(12):1203-14
pubmed: 22924465
J Bone Miner Res. 2011 Jan;26(1):193-208
pubmed: 20684029
Nature. 2011 Oct 12;478(7369):349-55
pubmed: 21993628
Ups J Med Sci. 2016 May;121(2):155-8
pubmed: 26998806
Diabetes. 2019 Oct;68(10):1950-1964
pubmed: 31345937
J Clin Invest. 2001 Dec;108(11):1631-8
pubmed: 11733558
Nat Genet. 2002 May;31(1):111-5
pubmed: 11923875
Endocrinology. 1999 Jan;140(1):96-105
pubmed: 9886812
Genes Dev. 2002 Jan 1;16(1):46-57
pubmed: 11782444
Cell Rep. 2013 Feb 21;3(2):401-10
pubmed: 23375376
Endocrinology. 2007 Feb;148(2):575-84
pubmed: 17110428
Science. 2014 May 9;344(6184):649-52
pubmed: 24797481
Cell. 2013 May 9;153(4):747-58
pubmed: 23623304
Am J Physiol Endocrinol Metab. 2013 Jul 1;305(1):E149-59
pubmed: 23673159
Curr Neurovasc Res. 2014;11(4):378-89
pubmed: 25219658
Cell. 2013 May 9;153(4):828-39
pubmed: 23663781
Diabetes. 2013 Aug;62(8):2843-8
pubmed: 23630298
Diabetes. 2015 Mar;64(3):856-66
pubmed: 25281430
Nat Rev Endocrinol. 2015 Apr;11(4):201-12
pubmed: 25687999
Nat Med. 2001 Oct;7(10):1133-7
pubmed: 11590437
Bone. 2012 May;50(5):1081-91
pubmed: 22387305
PLoS One. 2014 Aug 12;9(8):e104112
pubmed: 25117518
PLoS One. 2014 Mar 18;9(3):e92066
pubmed: 24642635
Diabetes. 2014 Mar;63(3):1021-31
pubmed: 24009262
J Transl Sci. 2016;1(3):83-85
pubmed: 26893943
Int J Endocrinol. 2015;2015:967673
pubmed: 25873961
J Cell Commun Signal. 2015 Mar;9(1):63-72
pubmed: 25657057
Nature. 1998 Feb 26;391(6670):900-4
pubmed: 9495343
Diabetologia. 2012 Dec;55(12):3331-40
pubmed: 22926403
PLoS One. 2012;7(10):e46986
pubmed: 23056550
J Biol Chem. 2013 Apr 26;288(17):11705-17
pubmed: 23471965
Sci Rep. 2016 Feb 12;6:20547
pubmed: 26867691
Dev Cell. 2015 Mar 9;32(5):535-45
pubmed: 25662175
Diabetes. 2015 Jun;64(6):1872-85
pubmed: 25999530
Nat Genet. 1999 Sep;23(1):32-40
pubmed: 10471495
J Endocr Soc. 2017 Apr 18;1(6):660-670
pubmed: 29264519
Tumour Biol. 2014 Nov;35(11):11147-51
pubmed: 25104090
Diabetologia. 2018 Sep;61(9):2054-2065
pubmed: 29754289
Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14717-22
pubmed: 9843955
Cell Metab. 2015 Jul 7;22(1):77-85
pubmed: 26094891
J Cell Commun Signal. 2007 Dec;1(3-4):159-64
pubmed: 18568428
J Clin Invest. 2003 Nov;112(10):1521-32
pubmed: 14617753
Sci Rep. 2017 May 11;7(1):1749
pubmed: 28496206
Nature. 2006 Sep 28;443(7110):453-7
pubmed: 16957737
J Cell Commun Signal. 2016 Jun;10(2):121-7
pubmed: 27098435
Nat Med. 2015 Apr;21(4):383-8
pubmed: 25751815
Nature. 2011 Aug 31;477(7362):90-4
pubmed: 21886162
Nature. 2005 Feb 17;433(7027):760-4
pubmed: 15716955
Endocr Pract. 2012 Sep-Oct;18(5):758-62
pubmed: 22784851
Diabetes. 2015 Apr;64(4):1284-98
pubmed: 25392241
Diabetes. 2002 Jan;51(1):55-65
pubmed: 11756323
Wound Repair Regen. 2010 Jul-Aug;18(4):426-32
pubmed: 20546556
Diabetes. 2011 Sep;60(9):2424-33
pubmed: 21810601
Matrix Biol. 2018 Aug;68-69:533-546
pubmed: 29330021
Nat Rev Drug Discov. 2011 Dec 01;10(12):945-63
pubmed: 22129992
Science. 2014 May 9;344(6184):630-4
pubmed: 24797482
Trends Biochem Sci. 2008 Oct;33(10):461-73
pubmed: 18789696
Sci Transl Med. 2019 Jun 19;11(497):
pubmed: 31217339
Sci Signal. 2019 Dec 03;12(610):
pubmed: 31796630

Auteurs

Rebeca Fernandez-Ruiz (R)

August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Rosselló 149-153, 08036, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Barcelona, Spain.
University of Barcelona, Barcelona, Spain.

Ainhoa García-Alamán (A)

August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Rosselló 149-153, 08036, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Barcelona, Spain.

Yaiza Esteban (Y)

August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Rosselló 149-153, 08036, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Barcelona, Spain.

Joan Mir-Coll (J)

August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Rosselló 149-153, 08036, Barcelona, Spain.
University of Barcelona, Barcelona, Spain.

Berta Serra-Navarro (B)

August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Rosselló 149-153, 08036, Barcelona, Spain.
University of Barcelona, Barcelona, Spain.

Marta Fontcuberta-PiSunyer (M)

August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Rosselló 149-153, 08036, Barcelona, Spain.

Christophe Broca (C)

CHU Montpellier, Laboratory of Cell Therapy for Diabetes (LTCD), Hospital St-Eloi, Montpellier, France.

Mathieu Armanet (M)

CHU Montpellier, Laboratory of Cell Therapy for Diabetes (LTCD), Hospital St-Eloi, Montpellier, France.

Anne Wojtusciszyn (A)

CHU Montpellier, Laboratory of Cell Therapy for Diabetes (LTCD), Hospital St-Eloi, Montpellier, France.
Service of Endocrinology, Diabetes and Metabolism, Lausanne University Hospital, Lausanne, Switzerland.

Vardit Kram (V)

Molecular Biology of Bones and Teeth Section, NIDCR, National Institutes of Health, Bethesda, MD, USA.

Marian F Young (MF)

Molecular Biology of Bones and Teeth Section, NIDCR, National Institutes of Health, Bethesda, MD, USA.

Josep Vidal (J)

August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Rosselló 149-153, 08036, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Barcelona, Spain.
Department of Endocrinology and Nutrition, Hospital Clinic of Barcelona, Barcelona, Spain.

Ramon Gomis (R)

August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Rosselló 149-153, 08036, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Barcelona, Spain.
University of Barcelona, Barcelona, Spain.
Universitat Oberta de Catalunya (UOC), Barcelona, Spain.

Rosa Gasa (R)

August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Rosselló 149-153, 08036, Barcelona, Spain. rgasa@clinic.cat.
Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Barcelona, Spain. rgasa@clinic.cat.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH